Iveric Bio Inc Reports Results For The Quarter Ended In December: Earnings Summary

IVERIC bio

01/03/2023 14:32

* IVERIC bio Inc  ISEE.OQ  reported a quarterly adjusted
loss
of 47 cents​​ per share for the quarter ended in December. The
mean expectation of ten analysts for the quarter was for a loss
of 37 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * IVERIC bio Inc's reported EPS for the quarter was a loss
of 47
cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * IVERIC bio Inc shares had fallen by 2.9% this quarter.
    * The company reported a quarterly loss of $59.06 million.
    * Wall Street's median 12-month price target for IVERIC bio
Inc is
$30.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 02:32 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.37          -0.47          Missed
 Sep. 30 2022      -0.40          -0.35          Beat
 Jun. 30 2022      -0.31          -0.41          Missed
 Mar. 31 2022      -0.29          -0.29          Met